Literature DB >> 15709703

Hydraulic strengthening affects the stiffness and strength of cortical bone.

Michael A K Liebschner1, Tony S Keller.   

Abstract

A nonlinear, interstitial fluid flow constitutive model for cortical bone was developed to study the strain-rate dependency of cortical bone apparent modulus (Ea). Nine representative volume element (RVE) structural models of cortical bone spanning an effective pore volume fraction P range of 1-40% were examined. Dynamic loading conditions were used to study the fluid flow contribution or hydraulic strengthening (HS) effect on Ea for each RVE model. The model indicated that there is an upper and lower asymptotic bound of strain-rate (10(+/-3) sec(-1)) above or below which there are no further HS effects on Ea. At certain strain-rates (10(-1) to 10(0) sec(-1)) variations in cortical bone porosity had little or no influence on Ea. At lower and higher frequencies, the loss tangent, hence the magnitude of viscoelastic effects is greater. For strain-rates less than 10(-1) sec(-1), lower porosity RVE models were always stiffer than higher porosity RVE models. A generalized power law model is proposed to account for the fact that HS in cortical bone exhibits an upper and lower asymptotic bound and is bi-modal in terms of strain-rate.

Entities:  

Mesh:

Year:  2005        PMID: 15709703     DOI: 10.1007/s10439-005-8960-0

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  11 in total

Review 1.  The Role of Water Compartments in the Material Properties of Cortical Bone.

Authors:  Mathilde Granke; Mark D Does; Jeffry S Nyman
Journal:  Calcif Tissue Int       Date:  2015-03-18       Impact factor: 4.333

2.  Hopkinson bar techniques for the intermediate strain rate testing of bovine cortical bone.

Authors:  T J Cloete; G Paul; E B Ismail
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2014-05-13       Impact factor: 4.226

3.  Osteoprotegerin prevents glucocorticoid-induced osteocyte apoptosis in mice.

Authors:  Robert S Weinstein; Charles A O'Brien; Maria Almeida; Haibo Zhao; Paula K Roberson; Robert L Jilka; Stavros C Manolagas
Journal:  Endocrinology       Date:  2011-07-19       Impact factor: 4.736

Review 4.  Glucocorticoids, osteocytes, and skeletal fragility: the role of bone vascularity.

Authors:  Robert S Weinstein
Journal:  Bone       Date:  2009-07-08       Impact factor: 4.398

Review 5.  Bone quality: the determinants of bone strength and fragility.

Authors:  Hélder Fonseca; Daniel Moreira-Gonçalves; Hans-Joachim Appell Coriolano; José Alberto Duarte
Journal:  Sports Med       Date:  2014-01       Impact factor: 11.136

Review 6.  From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis.

Authors:  Stavros C Manolagas
Journal:  Endocr Rev       Date:  2010-01-05       Impact factor: 19.871

7.  Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice.

Authors:  Robert S Weinstein; Chao Wan; Qinglan Liu; Ying Wang; Maria Almeida; Charles A O'Brien; Jeff Thostenson; Paula K Roberson; Adele L Boskey; Thomas L Clemens; Stavros C Manolagas
Journal:  Aging Cell       Date:  2009-12-28       Impact factor: 9.304

8.  Salvianolic acid B prevents bone loss in prednisone-treated rats through stimulation of osteogenesis and bone marrow angiogenesis.

Authors:  Liao Cui; Ting Li; Yuyu Liu; Le Zhou; Pinghua Li; Bilian Xu; Lianfang Huang; Yan Chen; Yanzhi Liu; Xiaoyan Tian; Webster S S Jee; Tie Wu
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

9.  In vivo evaluation of the presence of bone marrow in cortical porosity in postmenopausal osteopenic women.

Authors:  Janet Goldenstein; Galateia Kazakia; Sharmila Majumdar
Journal:  Ann Biomed Eng       Date:  2009-12-02       Impact factor: 3.934

10.  Effects of salvianolate on bone metabolism in glucocorticoid-treated lupus-prone B6.MRL-Fas (lpr) /J mice.

Authors:  Yanzhi Liu; Yang Cui; Xiao Zhang; Xiang Gao; Yanjie Su; Bilian Xu; Tie Wu; Wenshuang Chen; Liao Cui
Journal:  Drug Des Devel Ther       Date:  2016-08-09       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.